SkinVision Company

SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014.

Connections from

Technology: Diagnostics and consultation
Industry: Diagnosis, consultation, beauty education
Headquarters: Amsterdam, Netherlands
Founded Date: 01.01.2012
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: $0
Estimated Revenue: $1-10 Mn
Last Funding Date: 30.07.2018
Last Funding Type: Series B

Visit Website
info@skinvision.com
http://twitter.com/sknvsn
Register and Claim Ownership